Linda M. Richardson - 31 Dec 2021 Form 4 Insider Report for INTERCEPT PHARMACEUTICALS, INC.

Role
EVP & Chief Commercial Officer
Signature
/s/ Rocco Venezia, as attorney-in-fact
Issuer symbol
N/A
Transactions as of
31 Dec 2021
Net transactions value
-$19,727
Form type
4
Filing time
04 Jan 2022, 15:19:18 UTC
Previous filing
17 Nov 2021
Next filing
31 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICPT Common Stock Tax liability $19,727 -1,211 -4.7% $16.29 24,322 31 Dec 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock unit awards previously granted to the reporting person.

Remarks:

Exhibit List - Exhibit 24.1 - Power of Attorney